BioSig Technologies, Inc. Sample Contracts

COMMON STOCK PURCHASE WARRANT biosig technologies, inc.
BioSig Technologies, Inc. • January 12th, 2024 • Electromedical & electrotherapeutic apparatus

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received ___________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 12, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to __________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (1k)
AutoNDA by SimpleDocs
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • August 3rd, 2017 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus

This Registration Rights Agreement (this “Agreement”) is made and entered into as of April 6, 2017, among BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

Sample 1Sample 2Sample 3See All (1k)
COMMON STOCK PURCHASE WARRANT BIOSIG TECHNOLOGIES, INC.
BioSig Technologies, Inc. • July 31st, 2023 • Electromedical & electrotherapeutic apparatus • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Laidlaw & Company (UK) Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on January 31, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to 110,072 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between Laidlaw & Company (UK) Ltd. and the Company, dated as of July 26, 2023.

Sample 1Sample 2Sample 3See All (669)
COMMON STOCK PURCHASE WARRANT BIOSIG TECHNOLOGIES, INC.
BioSig Technologies, Inc. • October 16th, 2023 • Electromedical & electrotherapeutic apparatus • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Laidlaw & Company (UK) Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 16, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to 84,750 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between Laidlaw & Company (UK) Ltd. And the Company, dated as of July 26, 2023.

Sample 1Sample 2Sample 3See All (556)
COMMON STOCK PURCHASE WARRANT BIOSIG TECHNOLOGIES, INC.
Common Stock Purchase Warrant • January 24th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 24, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (489)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • November 13th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of November 8, 2023, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

Sample 1Sample 2Sample 3See All (480)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • October 16th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of October 12, 2023, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

Sample 1Sample 2Sample 3See All (375)
BIOSIG TECHNOLOGIES, INC. Common Stock (par value $0.001 per share) ATM Sales Agreement
BioSig Technologies, Inc. • May 17th, 2022 • Electromedical & electrotherapeutic apparatus • New York

BioSig Technologies, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Virtu Americas LLC (the “Agent”) as follows:

Sample 1Sample 2Sample 3See All (363)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • November 9th, 2017 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of November 3, 2017, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).

Sample 1Sample 2Sample 3See All (300)
CLASS B COMMON STOCK PURCHASE WARRANT
BioSig Technologies, Inc. • November 9th, 2017 • Electromedical & electrotherapeutic apparatus

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________________________, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the 3rd anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BIOSIG TECHNOLOGIES, INC., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (231)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • January 12th, 2024 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of January 12, 2024, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

Sample 1Sample 2Sample 3See All (222)
COMMON STOCK PURCHASE WARRANT
BioSig Technologies, Inc. • May 1st, 2018 • Electromedical & electrotherapeutic apparatus

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on __________, 2021 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to _______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (201)
COMMON STOCK PURCHASE WARRANT BIOSIG TECHNOLOGIES, INC.
BioSig Technologies, Inc. • January 21st, 2014 • Electromedical & electrotherapeutic apparatus

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (145)
INDEMNITY AGREEMENT
Indemnity Agreement • July 22nd, 2013 • BioSig Technologies, Inc. • Delaware

This Indemnity Agreement (this “Agreement”) dated as of May 2, 2013, is made by and between Biosig Technologies, Inc. (the “Company”), and Seth H.Z. Fischer (“Indemnitee”).

Sample 1Sample 2Sample 3See All (145)
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • November 9th, 2017 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of November 3, 2017, by and among BioSig Technologies, Inc., a Delaware corporation, with headquarters located at 12424 Wilshire Blvd, Suite 745, Los Angeles, CA 90025 (the "Company"), and the investors listed on the Schedule of Purchasers attached hereto (each, a "Purchaser" and collectively, the "Purchasers").

Sample 1Sample 2Sample 3See All (103)
OPEN MARKET SALE AGREEMENTSM
Open Market Sale • August 28th, 2020 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
Sample 1Sample 2Sample 3See All (95)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • September 11th, 2013 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of February 6, 2013, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

Sample 1Sample 2Sample 3See All (65)
UNDERWRITER COMMON STOCK PURCHASE WARRANT BIOSIG TECHNOLOGIES, INC.
BioSig Technologies, Inc. • June 29th, 2022 • Electromedical & electrotherapeutic apparatus

THIS UNDERWRITER COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date set forth above and on or prior to 5:00 p.m. (New York City time) on June __, 2027 (the “Termination Date”), but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to ______1 shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain underwriting agreement, dated as of June __, 2022, by and among the Company and Laidlaw & Company (UK) Ltd., as representative

Sample 1Sample 2Sample 3See All (35)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 16th, 2018 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), is entered into as of February 16, 2018 (the “Execution Date”), by and among BioSig Technologies, Inc., a Delaware corporation, with headquarters located at 12424 Wilshire Blvd., Suite 745, Los Angeles, California 90025 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).

Sample 1Sample 2Sample 3See All (27)
SERIES B COMMON STOCK PURCHASE WARRANT BIOSIG TECHNOLOGIES, INC.
Notice of Exercise • August 16th, 2018 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus

THIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on [●]1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to _______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (24)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 21st, 2014 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of August 15, 2014, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

Sample 1Sample 2Sample 3See All (19)
COMMON STOCK PURCHASE WARRANT BIOSIG TECHNOLOGIES, INC.
BioSig Technologies, Inc. • May 22nd, 2023 • Electromedical & electrotherapeutic apparatus

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 22, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (15)
AutoNDA by SimpleDocs
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • September 12th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of September 12, 2023, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

Sample 1Sample 2Sample 3See All (15)
UNIT PURCHASE AGREEMENT BY AND AMONG
Unit Purchase Agreement • May 1st, 2018 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

This UNIT PURCHASE AGREEMENT (this “Agreement”) is dated as of [●], 2018 by and among BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

Sample 1Sample 2Sample 3See All (10)
BIOSIG TECHNOLOGIES, INC. Common Stock (par value $0.001 per share) At-The- Market Issuance Sales Agreement
Sales Agreement • September 15th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

BioSig Technologies, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:

Sample 1Sample 2Sample 3See All (8)
4,341,667 Shares BIOSIG TECHNOLOGIES, INC. Common Stock AMENDED AND RESTATED UNDERWRITING AGREEMENT
Underwriting Agreement • June 29th, 2022 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

BioSig Technologies, Inc., a Delaware corporation (the “Company”), subject to the terms and conditions herein, proposes to sell to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement (this “Agreement”), on a best efforts basis, 4,341,667 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). This Amended and Restated Underwriting Agreement amends, restates and supersedes in its entirety the prior underwriting agreement dated as of June 24, 2022, by and between the Company and the Representative.

Sample 1Sample 2Sample 3See All (6)
COMMON STOCK PURCHASE WARRANT BIOSIG TECHNOLOGIES, INC.
BioSig Technologies, Inc. • December 28th, 2023 • Electromedical & electrotherapeutic apparatus

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the tenth anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to __________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price, of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Sample 1Sample 2Sample 3See All (5)
OFFICE LEASE Between DOUGLAS EMMETT 1993, LLC, a Delaware limited liability company as Landlord and BIOSIG TECHNOLOGIES, INC. a Delaware corporation as Tenant
Office Lease • July 22nd, 2013 • BioSig Technologies, Inc. • California

This Office Lease (this “Lease”), dated August 9, 2011, is by and between DOUGLAS EMMETT 1993, LLC, a Delaware limited liability company (“Landlord”), with an office at 808 Wilshire Boulevard, Suite 200, Santa Monica, California 90401, and BIOSIG TECHNOLOGIES, INC., a Delaware corporation (“Tenant”), with an office at 10161 Park Run Drive, Suite 150, Las Vegas, Nevada 89145.

Sample 1Sample 2Sample 3See All (4)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 24th, 2022 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March 21, 2022, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

Sample 1Sample 2Sample 3See All (4)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 13th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of February 8, 2023, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

Sample 1Sample 2Sample 3See All (4)
EMPLOYMENT AGREEMENT
Employment Agreement • July 22nd, 2013 • BioSig Technologies, Inc. • Delaware

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is dated as of March 1, 2013 and is entered into by and between Budimir Drakulic (the “Executive”) and BioSig Technologies, Inc. (the “Company”). The Company and the Executive shall be referred to herein as the “Parties.”

Sample 1Sample 2Sample 3See All (4)
COMMON STOCK PURCHASE WARRANT BIOSIG TECHNOLOGIES, INC.
BioSig Technologies, Inc. • March 16th, 2023 • Electromedical & electrotherapeutic apparatus • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Laidlaw & Company (UK) Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _________________2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to 67,611 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between Laidlaw & Company (UK) Ltd. And the Company, dated as of February 24, 2023.

Sample 1Sample 2Sample 3See All (4)
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • February 16th, 2018 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of February 16, 2018 (the “Execution Date”), is entered into by and between BIOSIG TECHNOLOGIES, INC., a Delaware corporation (the “Company”), and the undersigned buyers (each, a “Buyer” and collectively, the “Buyers”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain Securities Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

Sample 1Sample 2Sample 3See All (4)
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • November 21st, 2022 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of November 18, 2022, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

Sample 1Sample 2Sample 3
COMMON STOCK PURCHASE WARRANT BIOSIG TECHNOLOGIES, INC.
BioSig Technologies, Inc. • September 12th, 2023 • Electromedical & electrotherapeutic apparatus • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Laidlaw & Company (UK) Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 12, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to 67,565 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between Laidlaw & Company (UK) Ltd. And the Company, dated as of July 26, 2023.

Sample 1Sample 2Sample 3
Time is Money Join Law Insider Premium to draft better contracts faster.